Aichi, Japan

Hayao Nakanishi



Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Hayao Nakanishi: Innovator in Cell Isolation Technology

Introduction

Hayao Nakanishi is a prominent inventor based in Aichi, Japan, known for his significant contributions to the field of cell isolation technology. With a total of three patents to his name, Nakanishi has developed innovative methods and devices that enhance the efficiency of isolating rare tumor cells and circulating tumor cells from body fluids.

Latest Patents

Nakanishi's latest patents include a method for preparing glass slide specimens of cells. This device features a filter with recesses that capture target cells, such as circulating tumor cells, while allowing non-target cells to pass through. The glass slide is superposed onto the filter, facilitating the transfer of captured target cells. Additionally, a cover member seals a buffer solution within the recesses, preserving the target cells. Another notable patent is a device for isolating peripheral circulating tumor cells or rare cells, which utilizes a metal filter with depressions designed to capture these specific cells from body fluids.

Career Highlights

Throughout his career, Nakanishi has worked with notable organizations, including Optnics Precision Co., Ltd. and Aichi Prefecture. His work has significantly advanced the methodologies used in cell isolation, contributing to the medical and research fields.

Collaborations

Nakanishi has collaborated with esteemed colleagues such as Seiji Ito and Seichin Kinuta, further enhancing the impact of his innovations in the scientific community.

Conclusion

Hayao Nakanishi's contributions to cell isolation technology exemplify the importance of innovation in medical research. His patents reflect a commitment to improving the methods used in the detection and analysis of rare tumor cells, ultimately benefiting the field of oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…